Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
First Northwest Bancorp
FNWB
$108M
| $342K | ﹤0.01% |
+24,200
| New | +$320K |
|
|
CIM
2852
Chimera Investment
CIM
$993M
| $341K | ﹤0.01% |
8,333
-16,000
| -66% | -$671K |
|
2853
SIFCO Industries
SIF
$121M
| $340K | ﹤0.01% |
35,800
+2,200
| +7% | +$26.1K |
|
|
FMSA
2854
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $340K | ﹤0.01% |
144,669
-5,389
| -4% | -$14.2K |
|
|
LBMH
2855
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $336K | ﹤0.01% |
100,725
-2,057
| -2% | -$5.98K |
|
|
AUD
2856
DELISTED
Audacy, Inc.
AUD
| $334K | ﹤0.01% |
29,700
-15,000
| -34% | -$168K |
|
|
JST
2857
DELISTED
JINPAN INT'L LTD(COMMON)
JST
| $332K | ﹤0.01% |
86,600
+12,500
| +17% | +$48.7K |
|
|
VR
2858
DELISTED
Validus Hold Ltd
VR
| $329K | ﹤0.01% |
+7,100
| New | +$323K |
|
2859
Collegium Pharmaceutical
COLL
$913M
| $328K | ﹤0.01% |
11,933
-19,867
| -62% | -$419K |
|
|
OCRX
2860
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $328K | ﹤0.01% |
105,100
+46,900
| +81% | +$160K |
|
2861
Baytex Energy
BTE
$3B
| $327K | ﹤0.01% |
100,797
+32,500
| +48% | +$127K |
|
2862
McEwen Inc
MUX
$1.14B
| $327K | ﹤0.01% |
30,970
+27,970
| +932% | +$262K |
|
|
FWP
2863
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $325K | ﹤0.01% |
2,446
+375
| +18% | +$60.2K |
|
|
DDE
2864
DELISTED
Dover Downs Gaming & Entertain
DDE
| $323K | ﹤0.01% |
333,000
+14,400
| +5% | +$14.8K |
|
|
BOXC
2865
DELISTED
Brookfield Can Office Properties
BOXC
| $320K | ﹤0.01% |
17,000
+6,900
| +68% | +$138K |
|
|
SHYF
2866
DELISTED
The Shyft Group
SHYF
| $318K | ﹤0.01% |
102,200
+38,500
| +60% | +$149K |
|
2867
Xenon Pharmaceuticals
XENE
$6.21B
| $314K | ﹤0.01% |
39,105
+18,605
| +91% | +$159K |
|
|
MTEM
2868
DELISTED
Molecular Templates, Inc.
MTEM
| $314K | ﹤0.01% |
3,962
+1,209
| +44% | +$596K |
|
2869
Commercial Vehicle Group
CVGI
$130M
| $313K | ﹤0.01% |
113,300
+85,500
| +308% | +$307K |
|
|
GAU
2870
Galiano Gold
GAU
$547M
| $313K | ﹤0.01% |
214,200
+67,900
| +46% | +$107K |
|
|
ALO
2871
DELISTED
Alio Gold Inc
ALO
| $313K | ﹤0.01% |
226,820
+42,770
| +23% | +$79.6K |
|
2872
Euroseas
ESEA
$519M
| $311K | ﹤0.01% |
18,707
+830
| +5% | +$20K |
|
|
XBKS
2873
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $311K | ﹤0.01% |
16,920
+4,550
| +37% | +$86.4K |
|
|
PQUE
2874
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
| $310K | ﹤0.01% |
619,059
+579,259
| +1,455% | +$290K |
|
|
B
2875
DELISTED
Barnes Group Inc.
B
| $308K | ﹤0.01% |
+8,700
| New | +$325K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.